SEC
Whistleblower
Attorneys
Landmark Lawsuit Filed Against SEC to Protect Future Whistleblowers

May 28, 2019

H. Craig Dees, Provectus Biopharmaceuticals, Inc., Peter R. Culpepper

Financial Fraud

SANCTION AMOUNT: 5414145.46

Defendants: Provectus Biopharmaceuticals, Inc.
H. Craig Dees, Peter R. Culpepper

Former CEO and CFO allegedly misused funds of biopharmaceutical company for personal expenses, raiding the coffers by way of unauthorized and/or falsified perks and benefits that were not disclosed. CFO Culpepper settled the charges. A default judgment was entered against CEO Dees.

Named one of the top whistleblower practices/attorneys in the country by The New York Times, Wall Street Journal and NPR
Thank you for submitting some email to us.